Recombinant multi-species PEX1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PEX1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the AAA ATPase family, a large group of ATPases associated with diverse cellular activities. This protein is cytoplasmic but is often anchored to a peroxisomal membrane where it forms a heteromeric complex and plays a role in the import of proteins into peroxisomes and peroxisome biogenesis. Mutations in this gene have been associated with complementation group 1 peroxisomal disorders such as neonatal adrenoleukodystrophy, infantile Refsum disease, and Zellweger syndrome. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2013]
The Alternative Names of target: 5430414H02Rik,E330005K07Rik,HMLR1,PBD1A,PBD1B,PEX1,Peroxin-1,Peroxisomal ATPase PEX1,Peroxisome biogenesis disorder protein 1,Peroxisome biogenesis factor 1,Pex1,RGD1559939,ZWS,ZWS1

Target products collectionGo to PEX1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP9567-Ag-1/ GM-Tg-hg-IP9567-Ag-2 Human PEX1 protein Human
GM-Tg-rg-IP9567-Ag-1/ GM-Tg-rg-IP9567-Ag-2 Rat PEX1 protein Rat
GM-Tg-mg-IP9567-Ag-1/ GM-Tg-mg-IP9567-Ag-2 Mouse PEX1 protein Mouse
GM-Tg-cynog-IP9567-Ag-1/ GM-Tg-cynog-IP9567-Ag-2 Cynomolgus/Rhesus macaque PEX1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP9567-Ag-1/ GM-Tg-felg-IP9567-Ag-2 Feline PEX1 protein Feline
GM-Tg-cang-IP9567-Ag-1/ GM-Tg-cang-IP9567-Ag-2 Canine PEX1 protein Canine
GM-Tg-bovg-IP9567-Ag-1/ GM-Tg-bovg-IP9567-Ag-2 Bovine PEX1 protein Bovine
GM-Tg-equg-IP9567-Ag-1/ GM-Tg-equg-IP9567-Ag-2 Equine PEX1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP9567-Ag-1/ GM-Tg-hg-IP9567-Ag-2; GM-Tg-rg-IP9567-Ag-1/ GM-Tg-rg-IP9567-Ag-2;
GM-Tg-mg-IP9567-Ag-1/ GM-Tg-mg-IP9567-Ag-2; GM-Tg-cynog-IP9567-Ag-1/ GM-Tg-cynog-IP9567-Ag-2;
GM-Tg-felg-IP9567-Ag-1/ GM-Tg-felg-IP9567-Ag-2; GM-Tg-cang-IP9567-Ag-1/ GM-Tg-cang-IP9567-Ag-2;
GM-Tg-bovg-IP9567-Ag-1/ GM-Tg-bovg-IP9567-Ag-2; GM-Tg-equg-IP9567-Ag-1/ GM-Tg-equg-IP9567-Ag-2
Products Name PEX1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PEX1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PEX1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.